New biomarkers for diagnosis of polycystic ovary syndrome

New biomarkers for diagnosis of polycystic ovary syndrome

Background and aim The popular endocrine syndrome happening in women of reproductive age is polycystic ovary syndrome (PCOS). It is long understood that chronic ovaries with many tiny cysts, hyper vascularized androgen-secreting stroma, signs of extra androgen, and menstrual cycle irregularity are a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Farid I. Hassan, Mofeed F. Mohammed, Lamia H. Ali, Alaa A. M. Hussein
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-04-01
Series:	Al-Azhar Assiut Medical Journal
Subjects:	anti-müllerian hormone lipoprotein polycystic ovary sex hormone binding globulin triglycerides
Online Access:	https://journals.lww.com/10.4103/azmj.azmj_17_23
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic Utility of Various Hormones across Different Polycystic Ovary Syndrome Phenotypes: A Cross-sectional Study
by: Padala Ravi Kumar, et al.
Published: (2024-12-01)

Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review
by: Duru Shah, et al.
Published: (2024-01-01)

Comparing Assisted Reproductive Outcomes in Women with Different Polycystic Ovary Syndrome Phenotypes Undergoing Frozen Embryo Transfer
by: Anubhuti Patel, et al.
Published: (2023-10-01)

A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS)
by: Nirmal Kumar, et al.
Published: (2025-01-01)

Mastalgia Assesment and Hormonal Correlations in Patients with Polycystic Ovary Syndrome
by: Emel Kıyak Çağlayan, et al.
Published: (2015-04-01)

Correlation of Anti-Müllerian Hormone with Polycystic Ovarian Disease and its Relation with Age
by: Sara Omer Muhammed, et al.
Published: (2019-08-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Hormonal contraception in women with polycystic ovary syndrome: Contraceptive and non-contraceptive effects. A clinical lecture
by: Olga A. Pustotina
Published: (2024-12-01)

Role of Inhibin B and Ratio of Luteinizing: Follicle-Stimulating Hormones in Phenotyping Polycystic Ovarian Syndrome
by: Zainab G. Falh, et al.
Published: (2024-12-01)

Natural compounds in the management of polycystic ovary syndrome: a comprehensive review of hormonal regulation and therapeutic potential
by: Jingyi Yuan, et al.
Published: (2025-02-01)

High anti-Müllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study
by: Fei Zhao, et al.
Published: (2025-01-01)

Effect of Toxoplasma gondii Infection on the Level of Luteinizing and Follicle Stimulating Hormones in Women with Polycystic Ovary Syndrome
by: Muna Jalal Aziz, et al.
Published: (2024-10-01)

Causal association of sex hormone-related traits with Alzheimer’s disease: a multivariable and network Mendelian randomization analysis
by: Yan Zhang, et al.
Published: (2025-02-01)

Association Between SHBG Levels and Hypertensive Disorders of Pregnancy: A Systematic Review and Meta‐Analysis
by: Ajay Malvi, et al.
Published: (2025-01-01)

Impact of headache in women with polycystic ovary syndrome
by: Lina Zabulienë, et al.
Published: (2021-12-01)

Age and serum anti-Müllerian hormone levels as predictors of time to return of menses after chemotherapy
by: Madhavi-Priya Singh, et al.
Published: (2025-01-01)

Cardiovascular Risk Biomarkers in Women with and Without Polycystic Ovary Syndrome
by: Manjula Nandakumar, et al.
Published: (2024-12-01)

The effect of anti mullerian hormone and follicle stimulating hormone discordance on oocyte quality and live birth rates
by: Seray Kaya, et al.
Published: (2024-04-01)

Is There a Relationship between Serum Anti-Mullerian Hormone Levels and Abortion Rates in Patients Who Received In vitro Fertilisation-Embryo Transfer Cycles?
by: Pinar Karacin, et al.
Published: (2023-01-01)

Identification of a functional vitamin D response element in the promoter of goose anti-Müllerian hormone gene
by: Rong Chen, et al.
Published: (2025-02-01)

Geographical Diversity in the Age Specific Anti Müllerian Hormone Levels in Infertile Women: A Hospital Based Cohort Study
by: Mir Jaffar, et al.
Published: (2023-01-01)

Quality of Life in The Community of Women with Polycystic Ovary Syndrome (PCOS): A Phenomenology Study
by: Neina Qonita Istiqomah, et al.
Published: (2023-12-01)

Using machine learning to predict patients with polycystic ovary disease in Chinese women
by: Chen-Yu Wang, et al.
Published: (2025-01-01)

Identification of molecular characteristics in polycystic ovary syndrome using single-cell and transcriptome analysis
by: Xiaolin Zhu, et al.
Published: (2025-01-01)

Construction of fluorescent transgenic zebrafish Tg(amh:mCherry) and tracer analysis of its gonadal development
by: WU Jing, et al.
Published: (2024-12-01)

Perceived Effects and Prevention of Polycystic Ovary Syndrome among Women Living in Ilorin-South LGA, Kwara State, Nigeria
by: Abdulqudus Tosin Jamiu, et al.
Published: (2024-12-01)

Association of ultra-processed food-related metabolites with selected biochemical markers in the UK Biobank
by: Anthony Kityo, et al.
Published: (2025-01-01)

Animal experiments and network pharmacology to explore the anti-inflammatory mechanism of dapagliflozin in the treatment of polycystic ovary syndrome
by: Yong Liu, et al.
Published: (2025-12-01)

Exploring the therapeutic potential of Asparagus africanus in polycystic ovarian syndrome: a computational analysis
by: Riaz Sania, et al.
Published: (2024-12-01)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
by: Sweekruti Jena, et al.
Published: (2023-04-01)

Impact of Dienogest Alone or in Combination with Ethinylestradiol on the Quality of Life of Women with Endometriosis: A Prospective Cohort Study
by: Mujde Canday, et al.
Published: (2023-12-01)

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome
by: Ruihan Wang, et al.
Published: (2025-01-01)

Fecal propionate is a signature of insulin resistance in polycystic ovary syndrome
by: Sitong Dong, et al.
Published: (2025-01-01)

Ocular Surface Disease Severity in Polycystic Ovary Syndrome: is This Really Significant in Daily Life?
by: Demet Yabanoglu, et al.
Published: (2022-03-01)

The association between melatonin hormone and reproductive hormones in polycystic ovary syndrome: A case–control study
by: Ban Jabir Edan, et al.
Published: (2024-01-01)

The role of salivary antioxidant level in polycystic ovary syndrome women under assisted reproductive technology treatment: A case-control study
by: Narges Gholizadeh, et al.
Published: (2025-02-01)

Ovulation Induction Techniques in Polycystic Ovary Syndrome - Systematic Review
by: Daria Michałka, et al.
Published: (2025-01-01)

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Therapeutic efficacy and mechanism of artesunate for mouse model of polycystic ovary syndrome
by: WANG Xueling, et al.
Published: (2025-02-01)

Mitochondrial DNA oxidation and content in different metabolic phenotypes of women with polycystic ovary syndrome
by: Mailén Rojo, et al.
Published: (2025-01-01)